St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013, United States
NCT Number: NCT01382446
Examine the use of 0.12% Chlorhexidine Gluconate as an adjunct to current oral care protocol for trauma patients on ventilator support to decrease the incidence of Ventilator Associated Pneumonia and oral bacterial load.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Phoenix, Arizona, 85013, United States
To see a significant decrease in the bacterial load in the oral mucosa and subsequently, a decrease in the pathogenesis of Ventilator Associated Pneumonia through the use of an oral rinse containing 0.12% Chlorhexidine Gluconate as part of an oral care protocol. Current oral care protocol includes the use of 1.5% H2O2-coated swabs every four hours, toothbrushing with toothpaste every 12 hours, and use of continuous subglottic suction apparatus.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.12% Chlorhexidine Gluconate 15ml Twice Daily, administered via toothbrushing and swabbing teeth, tongue, gingiva, and oral mucosa.
Other names: Peridex
Brushing the teeth, tongue, gingiva, and oral mucosa twice daily with toothbrush and toothpaste.
Time frame: 18 Months
Examination of number of participants who do not develop oral bacteria and Ventilator Associated Pneumonia when an oral rinse containing 0.12% Chlorhexidine Gluconate is used as part of a oral care protocol.
St. Joseph's Hospital and Medical Center, Phoenix
Other
Evaluating Effectiveness of Chlorhexidine Gluconate Oral Care for Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03074552
Cross Infection, Disease Attributes
Thessaloniki, Greece
View Trial DetailsNCT06181669
Bacterial Infections, Bacterial Infections and Mycoses
Detroit, Michigan, United States
View Trial DetailsNCT07255742
Cross Infection, Disease Attributes
Tanta, Egypt
View Trial DetailsNCT05671328
Aspergillosis, Bacterial Infections and Mycoses
Lille, France
View Trial Details